312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • Volunteer
  • Contact Us
iBIO
  • About
    • Who We Are
    • Leadership
    • Contact
  • PROGRAMS
    • Events Calendar
    • Policy & Advocacy
      • Advocacy Center
      • Advocacy Toolkit
      • Rare Disease
    • STEMgirls Camp – Chicago
    • LabShare
    • STEMKits
    • StellarGirls
    • Volunteer with iBIO
  • Membership
    • Member Benefits
    • Business Solutions
    • Join iBIO
    • Volunteer with iBIO
  • Resources
    • News
    • Member Committees
    • Daily Newsletter
    • IBIO Reports
      • About Illinois
      • Investment Report
      • State Incentives
Select Page
Statement of John Conrad, President & CEO, Illinois Biotechnology Innovation Organization (iBIO) On the Passage of HB 4327 and HB 2371

Statement of John Conrad, President & CEO, Illinois Biotechnology Innovation Organization (iBIO) On the Passage of HB 4327 and HB 2371

by John Conrad | Jun 1, 2026 | iBIO News, Policy News

The passage of HB 4327 is a significant and long-overdue win for transparency, accountability, and — most importantly — for Illinois patients. For the first time, Illinois will have an independent, standardized accounting of how the 340B program actually operates in...
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X